A new app has been launched by Dementia Researcher, which aims to connect #dementia researchers worldwide, providing a unique space for collaboration, support, and professional growth ⬇️ bit.ly/4dVNCeh

We are delighted that our exciting paper looking at telomere length in #Friedreich’s ataxia is now out. This work in close collaboration with groups in Italy demonstrates its potential as an accessible disease #biomarker. Suran Nethisinghe Paola giunti UCL Queen Square Institute of Neurology …mentdisorders.onlinelibrary.wiley.com/doi/10.1002/md…

A lack of diversity in genomic studies for dementia could limit the effectiveness of targeted therapies in underrepresented populations, finds research by experts including Profs Henry Houlden and Sir John Hardy, and Drs Mie Rizig and Maryam Shoai UCL Queen Square Institute of Neurology ucl.ac.uk/news/2024/sep/…

Results from two UCL Queen Square Institute of Neurology papers presented at the 'Future of Dementia in Africa' conference highlight the need for more #diversity in dementia studies to improve targeted therapies for underrepresented populations. #WorldAlzheimersMonth #UCLDementia bit.ly/47qgh8J

Enjoyed Prof Sarah Tabrizi’s keynote lecture at #EHDN2024 🇫🇷 A tour de force of #HD — current progress, mechanisms and therapeutics UCL Huntington’s Disease Centre UCL Queen Square Institute of Neurology EHDN News

🚨Advance article alert - mutant PTPMT1 impairs cardiolipin metabolism causing human disease. Fantastic collaborative effort across several continents! Biallelic PTPMT1 variants disrupt cardiolipin metabolism and lead to a neurodevelopmental syndrome academic.oup.com/brain/article/…

In 2016, Dr Daniel Jiménez studied on the UCL Queen Square Institute of Neurology MSc Dementia course, 8 yrs later and he is leading research into familial Alzheimer’s disease & advising the Chilean Ministry of Health on a national plan for dementia ➡️ bit.ly/4d6T5Oe #UCLDementia #WorldAlzheimersMonth

This Thursday, join consultant neurologist Dr Cath Mummery's informative session on the latest information, #research and treatments available for those affected by #dementia. Online and in-person, visit here to learn more and sign up today: buff.ly/3zt1H3G

Delighted in Oxford with colleagues focussed on NMD patient research/best care -cant believe 16 yrs since I formed BMS with colleagues- great to see continued success- thanks to sponsors- therapy landscape changed dramatically! UCLH British Myology Society UCL Queen Square Institute of Neurology UCL Brain Sciences

We're hiring! Applications welcomed for this post to join our team as a research technician, working on Familial British Dementia, Deadline October 6th ucl.ac.uk/work-at-ucl/se…

Great visit and discussion on new therapies in neurology Alzheimer’s Research UK Drug Discovery @ UCL drug discovery with Johan Luthman, Head of R&D, Lundbeck UCL Queen Square Institute of Neurology and visits to our lab, Dr Amanda UK DRI Biomarker Factory and Duff Lab UK Dementia Research Institute UCL Brain Sciences Research at ARUK

Celebrating 3 years of successful collaboration between Dr. Magdalena Bak-Maier 💞🇵🇱 🏳️‍🌈 & UCL Queen Square Institute of Neurology! Our Technician & Research Assistant Leadership Development Programme has empowered many in their leadership journey. Excited to see UCL Brain Sciences continue its support for the future!

I had the pleasure of joining Gabby Logan for a dementia themed episode of The Mid•Point podcast — we discuss how to reduce your risk, new treatments, blood tests for Alzheimer’s, and more. Available, wherever you get your podcasts podfollow.com/midpoint/view

Newest pre-print from the team & great explainer thread from Charlie! After a lot of work in PSEN1 mutant neurons, we turned our attention to astrocytes & their response to inflammatory factors. Could PSEN1 mutations have a multiple hit role in fAD?

UCL has retained its position as a leading university for knowledge exchange in the fourth Knowledge Exchange Framework (KEF) results: bit.ly/4dhu3fq Research England, UCL Innovation & Enterprise #KEF4

Research by experts including Profs Henry Houlden and Sir John Hardy, and Drs Mie Rizig and Maryam Shoai (UCL Queen Square Institute of Neurology) has highlighted the need for more diverse genetic research to better understand #neurodegenerative diseases and improve treatments globally. bit.ly/3XGFSHa

I’m delighted to announce three new Ambassadors supporting our search #ForACure. Actors Ruth Wilson and Will Poulter join dementia researcher Prof Prof Selina Wray in the role. Thank you all for helping to change the ending for people living with dementia 🧡 alzheimersresearchuk.org/news/ruth-wils…

Our paper now out in Lancet Neurology - personalised treatment in Non Dystrophic Myotonia. Prof Michael Hanna NIHR UCLH Biomedical Research Centre UCL Queen Square Institute of Neurology Muscular Dystrophy UK UCL Brain Sciences UCLH thelancet.com/journals/laneu…

Delighted working with our great team & Dr Vino Vivekanandam delivering this trial impacting clinical practice -UCL researchers deliver breakthrough trial ⁦UCLH⁩ ⁦UCL Brain Sciences⁩ ⁦Muscular Dystrophy UK⁩ ⁦UCL News⁩ ⁦UCL_QS_CNMD⁩ ucl.ac.uk/ion/news/2024/…

Delighted that UCL has retained its position as a leading institution in the 4th Research England Knowledge Exchange Framework #KEF4! A testament to all the brilliant minds driving innovation and collaboration at UCL. 🚀 #KnowledgeExchange #Innovation bit.ly/3MSFBed